Maria Felice Brizzi

This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Unicyte Ev Ag, Alize Pharma Sas, Usicyte Ev Ag. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Felice Brizzi. Retrieved from https://idiyas.com/inventor/maria-felice-brizzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 5)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Years Active: 2013-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12208120 - Composition of extracellular vesicles (EVS) and medical uses thereof (2025-01-28),

2. 11464799 - Composition of extracellular vesicles (EVS) and medical uses thereof (2022-10-11),

3. 11110130 - Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia (2021-09-07),

4. 10716813 - Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia (2020-07-21),

5. 8476408 - Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease (2013-07-02),

Title: Maria Felice Brizzi: Innovator in Extracellular Vesicle Research

Introduction

Maria Felice Brizzi is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of medical research, particularly in the area of extracellular vesicles (EVs). With a total of 5 patents to her name, her work focuses on the therapeutic applications of these vesicles in treating ischemic diseases and injuries.

Latest Patents

One of her latest patents is titled "Composition of extracellular vesicles (EVS) and medical uses thereof." This invention relates to compositions of EVs that exhibit strong proangiogenic activity, making them effective in the therapeutic treatment of ischemic diseases and injuries, as well as in wound healing. The EVs used in these compositions can be derived from blood components or selected through potency tests for pro-angiogenesis. Additionally, the patent discloses a method for manufacturing a pharmaceutical preparation of EVs characterized by their strong proangiogenic activity.

Career Highlights

Throughout her career, Maria Felice Brizzi has worked with notable companies such as Unicyte Ev Ag and Alize Pharma Sas. Her innovative research has positioned her as a key figure in the development of new medical therapies utilizing extracellular vesicles.

Collaborations

Maria has collaborated with esteemed colleagues in her field, including Giovanni Camussi and Andrea Ranghino. These partnerships have further enhanced her research and contributions to the scientific community.

Conclusion

Maria Felice Brizzi is a trailblazer in the field of extracellular vesicle research, with a focus on their medical applications. Her innovative patents and collaborations highlight her commitment to advancing therapeutic solutions for ischemic conditions.

Profile summary based on public USPTO records.